This study is designed to investigate whether adjuvant radiotherapy after complete resection has a better survival for stage II or III thymoma.
It is confirmed by many studies that patients of thymoma with complete resection have better prognosis than those with either incomplete resection or without surgery. However,whether patients with stage II or III thymoma could benefit from adjuvant radiotherapy after complete resection remains controversial. The purpose of this study is to investigate whether adjuvant radiotherapy after complete resection can improve survival for stage II or III thymoma.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
238
50Gy/25Fx
Kailiang Wu
Shanghai, Shanghai Municipality, China
RECRUITINGDFS (Disease free survival)
from registration to disease progression or death.
Time frame: 5 years
OS(overall survival)
from registration to death
Time frame: 5 years
Number of Participants with Treatment- Related Adverse Events as Assessed by CTCAE v4.0
Adverse Events Assessed by CTCAE v4.0
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.